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BACKGROUND: Return to work is important financially, as a marker of 
functional status and for self-esteem in patients developing chronic illness. 
We examined return to work after first heart failure (HF) hospitalization.
METHODS: By individual-level linkage of nationwide Danish registries, we 
identified 21 455 patients of working age (18–60 years) with a first HF 
hospitalization in the period from 1997 to 2012. Of these patients, 11 880 
(55%) were in the workforce before HF hospitalization and comprised the 
study population. We applied logistic regression to estimate odds ratios for 
associations between age, sex, length of hospital stay, level of education, 
income, comorbidity, and return to work.
RESULTS: One year after first HF hospitalization, 8040 (67.7%) returned 
to the workforce, 2981 (25.1%) did not, 805 (6.7%) died, and 54 (0.5%) 
emigrated. Predictors of return to work included younger age (18–30 
versus 51–60 years; odds ratio [OR], 3.12; 95% confidence interval 
[CI], 2.42–4.03), male sex (OR, 1.22; 95% CI, 1.12–1.34), and level of 
education (long-higher versus basic school; OR, 2.06; 95% CI, 1.63–2.60). 
Conversely, hospital stay >7 days (OR, 0.56; 95% CI, 0.51–0.62) and 
comorbidity including history of stroke (OR, 0.55; 95% CI, 0.45–0.69), 
chronic kidney disease (OR, 0.46; 95% CI, 0.36–0.59), chronic obstructive 
pulmonary disease (OR, 0.62; 95% CI, 0.52–0.75), diabetes mellitus (OR 
0.76; 95% CI, 0.68–0.85), and cancer (OR, 0.49; 95% CI, 0.40–0.61) 
were all significantly associated with lower chance of return to work.
CONCLUSIONS: Patients in the workforce before HF hospitalization had 
low mortality but high risk of detachment from the workforce 1 year later. 
Young age, male sex, and a higher level of education were predictors of 
return to work.
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heart failure (HF) is associated with considerable morbidity, reduced quality of life, and a 5-year mortality of >50%.1–4 The gradual introduction of 
beneficial pharmacological treatment and cardiac de-
vices has led to significant improvements in prognosis 
and life expectancies of patients with HF during the past 
30 years.5 The improved prognosis combined with bet-
ter treatment and survival for patients with congenital 
and acute cardiovascular diseases has resulted in the 
lower incidence, but increasing prevalence of HF and 
led to HF being a major public health concern.4,6,7 How-
ever, most information on HF, including high mortality, 
is derived from studies of older patients, and there is 
a major knowledge gap regarding the consequences of 
living with HF in younger patients. Information on life ex-
pectancy and quality of life in younger patients with HF 
is limited, but information on another very important as-
pect of life in younger individuals with HF, the ability to re-
main in employment, is lacking. The ability to maintain a 
full-time job addresses a vital indirect consequence and 
cost of HF, beyond the usual clinical parameters such 
as mortality and hospitalization. Ability to work is more 
than just another measure of performance status. In ad-
dition its financial importance, employment is crucial for 
self-esteem and quality of life in patients with chronic 
illness.8 Detachment from the workforce increases the 
risk of depression and predicts trajectories of future 
mental health problems, and has even been associated 
with an increased risk of suicide.9–11 Obtaining informa-
tion on workforce inclusion, therefore, should shed light 
on an unstudied consequence of HF and provide a novel 
perspective on the impact of HF on the lives of those 
who, perhaps, have the most to lose from this condition. 
Hopefully better understanding of return to work after HF 
hospitalization might also allow development of strate-
gies to facilitate this important aspect of life in patients 
of working age with HF.
In this study, we used Danish health and administra-
tive registers to examine return to work and associated 
predictors, including age, level of education, and comor-
bidity, following first HF hospitalization in a nationwide 
cohort of patients.
MethODs
Data sources
A unique personal identification number is assigned to all resi-
dents in Denmark. This number is used in all Danish health 
and administrative registries and allows individual-level link-
age of information.12 In this study, we combined data from 
(1) the Danish database on all public welfare payments that 
contains weekly follow-up of all public welfare payments since 
1991, including sickness pension and disability benefits. (It 
has previously been validated for the study of the social and 
economic consequences of disease.13); (2) Danish nationwide 
administrative registries that hold information on sociodemo-
graphic characteristics, income, and education level; (3) the 
Danish National Patient Registry that holds information of all 
admissions to hospitals since 1978, and outpatient visits since 
1995, coded according to the International Classification of 
Diseases, Eighth Revision, and the International Classification 
of Diseases, Tenth Revision14; (4) the Danish Register of 
Medicinal Product Statistics (the national prescription reg-
istry) with information on all dispensed prescriptions since 
1995; (5) the National Population Registry that holds infor-
mation on vital status; and (6) The Danish Cause of Death 
Registry that holds information about the primary and underly-
ing cause of death.
study Population and Baseline Variables
The study population comprised patients who were 18 to 60 
years of age at the time of first hospitalization for HF in the 
period 1997 to 2012, and who were members of the work-
force (employed or available to work) before hospitalization 
(Figure 1). Because of the study outcome of return to work, 
only younger patients were relevant for inclusion in this study. 
First hospitalization for HF was identified by a primary or sec-
ondary discharge diagnosis of HF (online-only Data Supplement 
Table I) in the study period, and those with a prior HF hospital-
ization (1978–1996) were excluded. Each contact is coded 
by 1 main reason for hospitalization as the primary diagno-
sis, and, although there is no maximum number of secondary 
diagnoses, most are recorded with up to 4 diagnoses in total. 
The study population was stratified into 4 age groups (18–30, 
31–40, 41–50, and 51–60 years, respectively). Patients were 
followed in the Danish database on all public welfare payments 
for up to 16 years. We used a follow-up period of 4 years. 
In this period, no patients crossed the age where they could 
clinical PersPectiVe
What is new?
•	 In the present study, we investigated return to work 
(or recovery to the point of being able to work) 
among younger patients following a first hospital-
ization for heart failure. Loss of employment is an 
important consequence of chronic illness, both for 
the individual patient, and financially for society as 
a whole, as well.
What are the clinical implications?
•	One of three patients, who were employed/able to 
work before their first heart failure hospitalization, 
were not in the workforce 1 year later, despite a 
relatively low 1-year mortality (7%) among these 
patients.
•	We believe that our findings shed light on a hidden 
consequence of heart failure. By drawing attention 
to the high rate of nonreturn to work of younger 
patients, we hope to stimulate more research into 
why this happens and whether it can be avoided.
•	 Interventions that maintain employment in these 
patients could have beneficial effects on both their 
physical and mental health.
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receive a full state pension. Comorbidities, ie, ischemic heart 
disease, cancer, atrial fibrillation, chronic kidney disease, 
chronic obstructive pulmonary disease (COPD), diabetes mel-
litus, hypertension, and stroke, were identified by at least 1 
hospitalization in a 10-year period before and including index 
HF hospitalization (online-only Data Supplement Appendix I). 
History of diabetes mellitus was additionally identified by at 
least 1 filled prescription for glucose-lowering drugs 6 months 
before first HF hospitalization. Medical therapy before first HF 
hospitalization was defined by at least 1 filled prescription of 
the drug in the preceding 6 months. We assessed the use of 
the following drugs: angiotensin-converting enzyme inhibitors 
and angiotensin-II receptor blockers, aspirin, calcium chan-
nel blockers, digoxin, clopidogrel, mineralocorticoid receptor 
antagonists, statins, β-blockers, and loop diuretics. Average 
5-year family income before first HF hospitalization was calcu-
lated and summarized in quartiles.
Outcome Measures
Work status at the time of HF hospitalization was determined 
based on the 5 weeks leading up to the first HF hospitaliza-
tion. We subsequently evaluated work status in 5-week peri-
ods, 6 months after discharge, and repeated this evaluation 
at fixed time points every 6 months up to a total of 4 years of 
follow-up. The primary outcome was return to the workforce 
estimated in the 5-week period 1 year after the first HF hospital-
ization. Patients who were not on paid sick leave, had not taken 
early retirement, or had not received any support because of 
reduced working capability were classified as able to work, as 
were patients receiving state educational grants, paid mater-
nity leave, or some other leave of absence, because these 
social benefits are for persons who are capable of working. 
We used 5-week evaluation periods to reduce misclassification, 
ie, to ensure that patients with short-term sick leave were not 
classified as excluded from the workforce, a method that has 
been described previously.15 Therefore, in the main analyses, 
only patients with sick leave of 3 or more of the 5 evaluated 
weeks were classified as detached from the workforce. It is 
important to note that persons could return to work at later 
evaluations, and, in 4 years of follow-up, we recorded up to 6 
changes between attachment and detachment to the workforce 
per person. In sensitivity analyses, we altered our criterion for 
detachment from the workforce to 2 of 5 and 4 of 5 weeks, 
respectively. We subsequently assessed maintenance of work 
capability after first time return to work defined as a minimum 
of 3 consecutive weeks at any time during follow-up. In these 
patients, maintenance of work capability was evaluated by 
estimating time to 1, 3, and 12 weeks of consecutive detach-
ment. In sensitivity subgroup analyses, we separately assessed 
patients with and without significant comorbidities and those 
available to the workforce 1 year before first HF hospitalization.
Figure 1. Distribution of patient outcome following first hF hospitalization in patients employed/available to the 
workforce before hospitalization (18–30 years, n=429; 31–40 years, n=1064; 41–50 years, n=3059; and 51–60 
years, n=7328). 
The estimates account for early end of follow-up and are updated every 6 months. HF indicates heart failure.
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statistics
Baseline age was grouped (18–30, 31–40, 41–50, and 51–60 
years). Baseline patient characteristics were summarized sep-
arately for age groups. Differences between age groups were 
assessed by χ2 tests or Wilcoxon test. Return to work within 
1 year since first HF hospitalization was analyzed by multiple 
logistic regression, adjusting for age, sex, income, educa-
tion level, and comorbidities (ischemic heart disease, cancer, 
atrial fibrillation, chronic kidney disease, COPD, diabetes mel-
litus, hypertension, and stroke). Sex and comorbidity effects 
were tested for interactions with age group by likelihood ratio 
test. Patients were followed until date of emigration, death, 
or December 31, 2013. Patients who were not followed for 1 
year because of emigration were set to be detached from the 
workforce in logistic regression analyses. The percentages of 
patients who were available to the workforce were estimated 
at 6-month intervals in the first 4 years after the initial hos-
pitalization. Early end of follow-up because emigration and 
administrative censoring on December 31, 2013, was dealt 
with by estimating state occupation probabilities in an illness-
death model with recovery.16 Among patients who returned to 
the workforce for at least 3 consecutive weeks, we computed 
the risk of workforce detachment, defined as any detachment, 
respectively, minimum 3 or 12 weeks of consecutive detach-
ment, by using the Aalen-Johansen method.17 For all analyses, 
a P value<0.05 was considered statistically significant. The 
SAS statistical software package, version 9.2 (SAS Institute, 
Chapel Hill, NC) and R, version 3.0.2 (R development Core 
Team) was used for all analyses.
ethics
The study was approved by the Danish Data Protection Agency 
(2007-58-0015, GEH-2014–017, I-Suite-nr. 02735). In Denmark, 
ethical approval is not required for register-based studies.
resUlts
Baseline characteristics of the study Population
We identified 21 455 patients aged 18 to 60 years with 
first HF hospitalization between 1997 and 2012. Of 
these, 11 880 (55%) were in the workforce at the time 
of admission (Table 1), and these individuals formed the 
study cohort. Among these patients, 429 (4%) were in 
the youngest age group (18–30 years). Demographics 
and clinical characteristics according to age group are 
shown in Table 2. There were more men than women in all 
age groups, and the proportion of women decreased with 
age, from 36% in the youngest age group to 23% in the 
oldest age group. All comorbidities were most common 
in the oldest age group (51–60 years), with the excep-
tion of chronic kidney disease, and the oldest age group 
received the most pharmacotherapy (Table 2). Baseline 
characteristics of all patients with a first hospitalization 
for HF (n=21 455) stratified by workforce availability and 
age group are shown in Table 3. At baseline, 9575 (45%) 
patients were not in the workforce. In comparison with 
those in the workforce, these patients had higher fre-
quency of ischemic heart disease, cancer, chronic kidney 
disease, COPD, diabetes mellitus, and stroke. Postdis-
charge use of medication is shown in Table 4.
return to the Workforce Following First hF 
hospitalization
The fraction of individuals employed or available to work 
at the time of first HF hospitalization, and every 6 months 
thereafter, in each age group, is depicted in Figure 1. 
During 1 year before first HF admission, a decrease 
in the workforce fraction was seen in all age groups: 
15% in the oldest group, 11% in patients aged 41 to 
50 years, and 9% in the 2 youngest groups. One year 
after first HF hospitalization, 8040 (67.7%) returned to 
the workforce, 2981 (25.1%) did not, 805 (6.7%) died, 
and 54 (0.5%) emigrated, with return to work most likely 
among the youngest patients (81%). Notably, however, 
among patients alive 1 year after first HF hospitaliza-
tion, 27% of patients were detached from the workforce. 
By contrast, 1-year mortality was low, ranging from 
4% to 8%, and was highest in the oldest age group 
(Figure 1). We assessed return to work among patients 
with (n=9385) and without (n=2495) significant comor-
table 1. Occupational status at time of First heart Failure hospitalization according to age group
age group, n (%)
all
(n=21 455)
18–30 y
(n=572)
31–40 y
(n=1558)
41–50 y
(n=5073)
51–60 y
(n=14 252)
In the workforce 11 880 (55) 429 (75) 1064 (68) 3059 (61) 7328 (51)
  Employed 9262 (43) 217 (38) 731 (47) 2393 (47) 5921 (42)
  Study/maternity leave 492 (2) 98 (17) 63 (4) 27 (1) 304 (2)
  Unemployed 2126 (10) 114 (20) 270 (17) 639 (13) 1103 (8)
Not in the workforce 9575 (45) 143 (25) 494 (32) 2014 (40) 6924 (49)
  Sick leave 2346 (11) 57 (10) 153 (10) 571 (11) 1565 (11)
  Subsidized work 615 (3) 8 (1) 28 (2) 153 (3) 426 (3)
  Early retirement 6614 (31) 78 (14) 313 (20) 1290 (25) 4933 (34)
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bidity, ie, no history of stroke, diabetes mellitus, chronic 
kidney disease, COPD, and cancer. During 4 years of 
follow-up, patients without comorbidity had a lower mor-
tality and higher attachment to the workforce (Figure 2). 
Follow-up of return to work on all patients is depicted 
in online-only Data Supplement Figure I. Among patients 
table 2. Baseline characteristics of Patients in the Workforce Before First hospitalization for heart Failure 
(n=11 880).
age group, mean±sD or n (%)
P Value 
18–30 y
(n=429)
31–40 y
(n=1064)
41–50 y
(n=3059)
51–60 y
(n=7328)
Age, mean±SD 24.9±3.7 36.2±2.9 46.3±2.8 56.1±2.8 <0.0001
Male 274 (64) 732 (69) 2323 (76) 5660 (77)  
Highest education level     <0.0001
  Basic school <10 y 201 (47) 341 (32) 1006 (33) 2367 (32)  
  High school, +3 y 59 (14) 58 (5) 140 (5) 217 (3)  
  Vocational education 91 (21) 386 (36) 1209 (40) 3043 (42)  
  Short/medium higher, +2–4 y 35 (8) 144 (14) 396 (13) 1049 (14)  
  Long higher, +≥5 y 2 (0.4) 61 (6) 125 (4) 337 (5)  
  Unknown 41 (7) 74 (7) 183 (6) 315 (4)  
Income group*     <0.0001
  Q1 (lowest) 294 (69) 219 (21) 475 (16) 1059 (14)  
  Q4 (highest) 16 (4) 288 (27) 1057 (35) 2725 (37)  
Hospital stay, days     <0.0001
  0–2 161 (38) 348 (33) 1057 (35) 2343 (32)  
  3–7 124 (29) 350 (33) 1106 (36) 2849 (39)  
  >7 144 (34) 366 (34) 896 (29) 2136 (29)  
Comorbidity
  Ischemic heart disease 16 (4) 109 (10) 613 (20) 1742 (24) <0.0001
  Atrial fibrillation 19 (4) 74 (7) 239 (8) 951 (13) <0.0001
  Cancer 10 (2) 10 (1) 60 (2) 259 (4) <0.0001
  Chronic obstructive pulmonary disease 0 (0) 11 (1) 87 (3) 401 (5) <0.0001
  Diabetes mellitus 14 (3) 60 (6) 305 (10) 1040 (14) <0.0001
  Hypertension 26 (6) 106 (10) 524 (17) 1391 (19) <0.0001
  Chronic kidney disease 15 (4) 35 (3) 65 (2) 143 (2) 0.002
  Stroke 5 (1) 16 (2) 74 (2) 234 (3) <0.0001
Pharmacotherapy† 
  Loop diuretics 110 (26) 432 (41) 1475 (48) 4172 (57) <0.0001
  Antiplatelets, any 26 (6) 237 (22) 1187 (39) 3325 (45) <0.0001
  β-Blockers 143 (33) 528 (50) 1742 (57) 4228 (58) <0.0001
  Statins 10 (2) 155 (15) 886 (29) 2519 (34) <0.0001
  ACE-I/ARB 180 (42) 610 (57) 2112 (69) 5110 (70) <0.0001
  Thiazides 21 (5) 104 (10) 334 (11) 1078 (15) <0.0001
  Ca2+ channel blockers 22 (5) 90 (8) 406 (13) 1329 (18) <0.0001
  Digoxin 46 (11) 159 (15) 529 (17) 1643 (22) <0.0001
 Mineralocorticoid receptor antagonists 49 (11) 191 (18) 618 (20) 1585 (22) <0.0001
Values displayed are mean±SD or number (%). ACE-I indicates angiotensin-converting enzyme inhibitors; and ARB- angiotensin-II receptor blockers.
*Average 5-year family income before event, in quartiles.
†Filled prescriptions 180 days before admission.
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not in the workforce at baseline, 1151 (12%) died during 
the first year after first HF hospitalization.
Predictors of return to the Workforce
We estimated the odds ratios with 95% confidence inter-
vals for return to the workforce at 1 year in a multiple 
regression model among patients in the workforce be-
fore first HF hospitalization (Figure 3). Younger age, male 
sex, higher educational attainment, and higher income 
were associated with a higher likelihood of returning to 
the workforce. Conversely, several comorbidities such 
as stroke, diabetes mellitus, chronic kidney disease, 
COPD, and cancer were associated with a lower chance 
of returning to the workforce. However, this association 
was not found for ischemic heart disease, atrial fibrilla-
tion, or hypertension.
time to return to the Workforce and 
Maintenance of Work
During 4 years of follow-up, 10 324 patients (87%) 
returned to work. More than half were back to work 
shortly after their first HF hospitalization, and, after 
26 weeks, 75% had returned to work. Among patients 
who returned to work for a minimum of 3 consecutive 
weeks, 52% were detached from the workforce after 
3 years when no sick leave from the workforce was 
table 3. Baseline characteristics of all Patients With a First hospitalization for heart Failure 
From 1997 to 2012 (n=21 455)
Workforce availability
Yes no
Age group, y 18–40 41–60 18–40 41–60
Patients, n 1493 10 387 637 8938
Age, mean±SD 32.9±6.0 53.2±5.3 34.2±5.4 54.2±4.9
Male 1006 (67) 7983 (77) 393 (62) 5787 (65)
Highest education level
  Basic school <10 y 542 (36) 3373 (32) 351 (55) 4434 (50)
  High school, +3 y 117 (8) 357 (3) 37 (6) 209 (2)
  Vocational education 477 (32) 4252 (41) 169 (27) 3050 (34)
  Short/medium higher, +2–4 y 179 (12) 1445 (14) 29 (5) 777 (9)
  Long higher, +≥5 y 63 (4) 462 (4) 11 (2) 138 (5)
  Unknown 115 (8) 498 (5) 40 (6) 330 (4)
Income group*
  Q1 (lowest) 513 (34) 1534 (15) 255 (40) 3061 (34)
  Q4 (highest) 304 (20) 3782 (36) 53 (8) 1225 (14)
Hospital stay, days
  0–2 509 (34) 3400 (33) 253 (40) 3174 (36)
  3–7 474 (32) 3955 (38) 188 (30) 2988 (33)
  >7 510 (34) 3032 (29) 196 (31) 2776 (31)
Comorbidity
  Ischemic heart disease 125 (8) 2355 (23) 82 (13) 2615 (29)
  Atrial fibrillation 93 (6) 1190 (11) 30 (5) 970 (11)
  Cancer 20 (1) 319 (3) 22 (3) 588 (7)
  Chronic obstructive pulmonary disease 11 (1) 488 (5) 16 (3) 942 (11)
  Diabetes mellitus 74 (5) 1345 (13) 89 (14) 2067 (23)
  Hypertension 132 (9) 1915 (18) 81 (13) 2113 (24)
  Chronic kidney disease 50 (3) 208 (2) 43 (7) 493 (6)
  Stroke 21 (1) 308 (3) 19 (3) 681 (8)
Values displayed are mean±SD or number (%).
*Average 5-year family income before event, in quartiles.
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accepted. When sick leave up to 3 and 12 weeks was 
accepted, 46% and 38%, respectively, were detached 
from the workforce after 3 years. Of these patients, 
52% were detached from the workforce after 3 years 
when no sick leave from the workforce was accepted. 
When sick leave up to 3 and 12 weeks was accepted, 
46% and 38%, respectively, were detached from the 
workforce after 3 years.
sensitivity analyses
We analyzed return to the workforce in patients with 
HF as the primary diagnosis and found no significant 
difference in 1 year return to workforce in compari-
son with patients with HF as a secondary diagnosis at 
first hospitalization for HF (P=0.33). No differences in 
terms of return to work at 1 year were seen when we 
required 2 or 4 of 5 weeks of sick leave to be classi-
fied as detached from the workforce (data not shown). 
In a multiple logistic regression model including car-
diovascular medications we found that angiotensin-
converting enzyme inhibitors/angiotensin II receptor 
blockers, β-blockers, and digoxin were significantly 
associated with increased likelihood of return to work. 
Conversely, loop diuretics and mineralocorticoid re-
ceptor antagonists were significantly associated with 
lower likelihood of return to work (online-only Data 
Supplement Figure II).
DiscUssiOn
We investigated the association between first hospital-
ization for HF and subsequent return to the workforce 
in patients of working age. One year after first HF hos-
pitalization, the proportion of patients who returned to 
the workforce, as either employed or available to the 
workforce, was markedly reduced from before admis-
sion in all age groups, with nearly one-third of patients 
no longer capable of working. In multiple regression 
analyses, younger age, male sex, higher income, and 
higher level of education were positively associated 
with return to work, whereas certain comorbidities 
(stroke, diabetes mellitus, cancer, COPD, and chronic 
kidney disease) were associated with detachment from 
the workforce.
table 4. Pharmacotherapy 90 Days after Discharge among those Who are still 
alive (n=11 501) Defined by Filled Prescriptions
age group, y
18–30 31–40 41–50 51–60
Patients, n 421 1042 2991 7047
Pharmacotherapy, n (%)
  Loop diuretics 138 (33) 503 (48) 1604 (54) 4234 (60)
  Antiplatelets, any 32 (8) 263 (25) 1193 (40) 3221 (46)
  β-Blockers 193 (46) 647 (62) 2020 (68) 4603 (65)
  Statins 15 (4) 172 (18) 961 (32) 2626 (37)
  ACE-I/ARB 212 (50) 697 (67) 2288 (77) 5308 (75)
  Thiazides 26 (6) 86 (8) 281 (9) 686 (10)
  Ca2+ channel blockers 25 (6) 108 (10) 338 (11) 989 (14)
  Digoxin 47 (11) 185 (18) 590 (20) 1712 (24)
  Mineralocorticoid receptor antagonists 70 (17) 264 (25) 805 (27) 1898 (27)
Ejection fraction is not known. ACE-I indicates angiotensin-converting enzyme inhibitors; and ARB, angiotensin-
II receptor blockers. P <0.0001.
Figure 2. Outcome after 4 years.  
Distribution of 4 years of outcomes following first HF hos-
pitalization in patients employed/available to the workforce 
with (n=2495) and without (n=9385) history of chronic kidney 
disease, COPD, diabetes mellitus, stroke, or cancer. The 
estimates account for the early end of follow-up. C indicates 
comorbidity; and NC, no comorbidity.
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Work capability among HF patients has, to our knowl-
edge, not been assessed before. HF has been shown to 
reduce quality of life, based on standardized question-
naires.3 The Danish database on social benefits offers 
a unique opportunity to assess an objective measure of 
disease impact in the form of loss of employment and 
the provision of disability benefits and sick pensions. 
We believe that inclusion in the workforce is not only a 
tangible measurement of quality of life and performance 
status, but also a consequence likely to have broader 
implications for self-esteem and mental health in these 
younger patients of working age.9,11 The relation be-
tween health status and inclusion in the workforce may 
be 2-way, because changes in employment have been 
related to worsened self-reported health measures.18,19 
Likewise, sick leave per se, is associated with increased 
risk of unemployment and disability pension independent 
of health status.20
At the time of first hospitalization for HF, nearly half 
of the patients had been detached from the workforce. 
Evidently, some of the patients had already been di-
agnosed and treated for HF in outpatient clinics or by 
their general practitioner, whereas others might have 
had HF undiagnosed, which likely could have led to im-
paired functional level and failure to meet the physical 
requirements of full-time employment. In this study, we 
focused on the patients employed or available to work 
up till the time of HF hospitalization and discharged 
from the hospital alive. Our primary end point was re-
turn to the workforce, but mortality is of great impor-
tance. In comparison with other HF studies, we found 
a low mortality rate.4 This may be explained by the 
fact that we exclusively examined patients between 18 
and 60 years of age, ie, young patients with a better 
prognosis. The MAGGIC (Meta-analysis Global Group in 
Chronic Heart Failure) meta-analysis reported a similar 
1-year mortality of between 6.5% and 7.5% in patients 
aged <60 years.21,22 Another explanation might be that 
our patients were part of the workforce before admis-
sion and thus were healthier than even those in a gen-
eral all-comers population of young patients with HF. In 
accordance with this, we found mortality to be nearly 
twice as high among patients not in the workforce 
before hospitalization.
Among patients in the workforce before hospitaliza-
tion, we found that a significant fraction was detached 
from the workforce when evaluated 1 year later. These 
findings, seen across all age groups, confirm that HF 
significantly reduces a patient’s capacity to maintain a 
normal life and live independently. Other diseases with 
putative severe consequences on work capability have 
been investigated by using the same Danish data.15,23 
It is striking that a higher proportion of patients surviv-
ing pneumococcal meningitis and viral encephalitis were 
working 1 year after hospitalization (93% and 84%, 
respectively) than of those hospitalized for HF.23 Returns 
Figure 3. Multiple logistic regression model of predictors of return to the workforce 1 year after first  
hospitalization for hF among patients in the workforce before hospitalization (n=11 880).  
CI indicates confidence interval; COPD, chronic obstructive pulmonary disease; and OR, odds ratio.
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to work of HF patients were more in line with patients 
alive 30 days after an out-of-hospital cardiac arrest in 
which 58% were capable of working 1 year after their 
cardiac arrest.15 It is clearly important, therefore, to 
try to better understand why this detachment from the 
workforce occurs. For example, is it solely attributable 
to reduced functional capacity or might it reflect the psy-
chological or other consequences of a diagnosis of HF? 
Might it reflect fear among physicians (to advise return 
to work because of perhaps inappropriate concerns 
about risk) or employers (perhaps to take back patients 
thought, wrongly, to be at high risk of death) rather than 
just among patients, their families, and caregivers? Bet-
ter understanding of the causes might suggest whether 
loss of working capacity might be prevented by, for 
example, intensive rehabilitation, psychological, educa-
tional, or some other therapeutic intervention. This is 
of great importance because removal from the labor 
market and dependence on public benefits has great 
economic consequences that go beyond the already 
significant economic burden these patients place on 
the healthcare system, and potentially many other so-
cial, psychological, and medical implications, as well. It 
is perhaps not surprising that the youngest age group 
had the highest proportion returning to and maintaining 
capability of working, which could be because of a lower 
prevalence of comorbidities and a greater determination 
to stay employed. This is in accordance with other stud-
ies on work capability.15,23
The presence of comorbidities was associated with 
a reduced chance of return to work 1 year after HF 
hospitalization. Cancer, chronic kidney disease, COPD, 
and stroke showed the strongest associations, but dia-
betes mellitus also had a significant association with a 
reduced chance of return to work. These findings em-
phasize the importance of a multidisciplinary approach 
to the management of HF patients.24,25 For example, in 
a young person with cancer and HF as a result of che-
motherapy, it may be the cancer rather than HF that 
prevents full functional and psychological recovery and 
return to work. In keeping with this, we saw a strong 
correlation between comorbidity and a lower chance of 
return to work. Nevertheless, we still found that a large 
proportion of those with HF and no comorbidity also 
failed to return to the workforce (Figure 2).
contribution of national Policies regarding 
healthcare insurance and employment
Our results are based on the Danish healthcare and so-
cial systems and may not be applicable to other coun-
tries. The Danish healthcare system is run and managed 
by the state and is tax financed. Access to healthcare 
services is not affected by employment status and is 
free of charge. Denmark has a low percentage of unem-
ployment in comparison with other Western countries. 
No one is forced to retire, but people can receive a 
full state-funded pension at the age of 65 years if they 
were born before January 1, 1959, otherwise at the 
age of 67 years.
strengths and limitations
The main strength of our study was the completeness 
of data, and the combination of detailed weekly updated 
information of patients’ occupational status and data on 
vital status and hospitalizations. The main limitation of 
the study is the lack of important clinical information on 
patients, perhaps most importantly left ventricular ejec-
tion fraction and symptoms including New York Heart 
Association functional class. Also, we chose to look at 
first hospitalization and disregarded prior outpatient con-
tacts attributable to HF. This means some patients have 
diagnosed and treated HF, but we chose this approach 
to ensure the inclusion of patients with similar severity 
of disease, ie, in need of a hospitalization. We identified 
patients by a primary or secondary discharge diagnosis 
of HF at first hospitalization with HF, and no significant 
difference in 1-year return to work was found between 
these groups of patients. Occupational status could be 
subject to misclassification. However, our results were 
essentially unchanged when we changed our criterion 
of sick leave. Because of the reliance on prior hospital-
izations to identify comorbidity, we may have underesti-
mated the burden of disorders usually dealt with by the 
patients’ general practitioners, such as hypertension and 
depression. Last, our study is observational; thus, we 
report associations and not necessarily causal connec-
tions. HF is a diagnosis with different causes and patho-
physiology in different age groups. Therefore, results 
from comparison of HF patients in different age groups 
have to be interpreted with some caution. The motivation 
for return to work probably changes with age. Older pa-
tients closer to retirement age might not return to work 
because of the lack of necessity and not because of 
poor performance status. Because of emigration, the 
1-year outcome was not available for 54 patients (0.5%). 
In our logistic regression analyses, these patients were 
set to be detached from the workforce. This potentially 
incurred a small bias.
cOnclUsiOns
Among individuals in the workforce before first HF hos-
pitalization, we found that, despite a low mortality, 30% 
were not in the workforce 1 year later. Younger age, 
male sex, and a higher level of education and income 
were associated with return to work, whereas comor-
bidities and longer hospital stays reduced the chance of 
returning to work. The inability to return to work might 
be an additional quality metric for the care of HF pa-
tients, and to address this could have high public health 
Rørth et al
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and socioeconomic impact and improve quality of life 
and prognosis.
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